Abstract

BackgroundHospital-onset Clostridioides difficile infection (HO-CDI) is a major source of morbidity and mortality. The objective of this research was to evaluate the reduction in HO-CDI through the use of a launderable bed barrier (BB) and an antibiotic stewardship program (ASP).MethodsA retrospective pre-post study was conducted at an acute care hospital in Kentucky. The preintervention period was September 2014 through March 2016. The BB and the ASP were introduced in April 2016, and the post-intervention period for this study ended September 2018. The rate of HO-CDI was calculated from the actual number of HO-CDI divided by the number of patient days each month. The number of defined daily doses of antibiotic therapy was measured each quarter. Hand disinfection compliance, length-of-stay (LOS), case mix index (CMI), and average age of patients were collected to control for confounding in the regression models.ResultsThere were 34 HO-CDIs and 42 672 patient days in the pre-intervention period and 31 HO-CDIs and 65 882 patient days in the post-intervention period. The average monthly count of HO-CDI was 1.79 (SD 1.51) and 1.03 (SD 0.96) during the pre- and post-periods, respectively. The average monthly rate (per 10 000 patient-days) was 7.94 (SD 6.30) in the pre-intervention period and 4.71 (SD 4.42) during the post-intervention period. The use of antibiotics decreased by 37% (p <0.0001) over the study period. The combination of the BB and the ASP were associated with a 59% (95% CI 36–96%, p 0.034) reduction in HO-CDI.ConclusionsThe use of a launderable BB and the ASP were associated with a statistically and clinically significant reduction in HO-CDI in the acute care hospital setting.

Highlights

  • Hospital-onset Clostridioides difficile infection (HO-CDI) is a major source of morbidity and mortality

  • The combination of the bed barrier (BB) and the antibiotic stewardship program (ASP) were associated with a significant reduction in HO-CDIs

  • A recent study of hospitals in the Emerging Infections Program showed that, while other healthcare acquired infections (HAIs) are decreasing, rates of HO-CDI were not significantly lower from 2011 to 2015.2 The National Healthcare Safety Network (NHSN) indicated that there has been a slight decrease in HO-CDI as of 2016; there were 95 530 HO-CDIs reported by 3605 acute care hospitals to NHSN for calendar year 2016.3 These HO-CDIs have added and estimate $4.8 billion in costs to acute care hospitals in the US.[4]

Read more

Summary

Introduction

Hospital-onset Clostridioides difficile infection (HO-CDI) is a major source of morbidity and mortality. It was estimated that in 2011 there were approximately 453 000 CDIs in the US, with an estimated 104 400 HO-CDIs and 29 300 deaths.[1] A recent study of hospitals in the Emerging Infections Program showed that, while other healthcare acquired infections (HAIs) are decreasing, rates of HO-CDI were not significantly lower from 2011 to 2015.2 The National Healthcare Safety Network (NHSN) indicated that there has been a slight decrease in HO-CDI as of 2016; there were 95 530 HO-CDIs reported by 3605 acute care hospitals to NHSN for calendar year 2016.3 These HO-CDIs have added and estimate $4.8 billion in costs to acute care hospitals in the US.[4] There has been a major emphasis on antibiotic stewardship programs (ASP) in order to decrease HO-CDI.[5,6] View this license’s legal deed at http://creativecommons.org/licenses/by/4.0 and legal code at http://creativecommons.org/licenses/by/4.0/legalcode for more information

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call